肾毒性化合物二甘醇的神经毒性效应
本研究用雄性Wistar-Han大鼠口服二甘醇(4–6 g/kg,每12或24小时一次)建立亚急性中毒模型,观察7天。43只给药动物中11只出现急性肾损伤(BUN和肌酐升高)。发生肾损伤的动物肾与脑组织二甘醇酸蓄积明显增加,脑脊液总蛋白明显升高,前肢握力及运动、直立活动显著下降。作者认为神经症状仅在同时存在二甘醇酸蓄积和肾损伤时出现。
要点
- 二甘醇口服剂量为4–6 g/kg,每12或24小时给药一次,观察7天,属动物实验方案,非人体推荐剂量。
- 43只给药动物中11只发生急性肾损伤,以BUN和肌酐升高确认。
- 仅发生肾损伤的动物出现脑脊液总蛋白明显升高及前肢握力、运动与直立活动显著下降。
- 肾损伤动物肾与脑组织二甘醇酸蓄积较无肾损伤动物明显增加。
- 提示临床遇二甘醇中毒时应关注肾功能与延迟出现的神经症状,但机制关联尚需人体研究验证。
适用人群与场景
- 雄性Wistar-Han大鼠亚急性二甘醇中毒模型;原文未提及人体适用人群、纳入或排除标准。
诊断标准与关键阈值
- 急性肾损伤以BUN和肌酐水平升高确认(原文未给出具体阈值)。
- 神经毒性评估包括前肢握力、运动活动和直立活动测试,以及脑脊液总蛋白测定。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 发生急性肾损伤的动物出现前肢握力下降、运动与直立活动减少及脑脊液总蛋白升高,提示肾损伤后需警惕延迟神经毒性。
研究设计与关键结果
- 研究类型:亚急性动物实验;样本量:43只雄性Wistar-Han大鼠接受二甘醇4–6 g/kg口服,每12或24小时一次,观察7天。
- 11只动物发生急性肾损伤(BUN和肌酐升高)。
- 肾损伤动物肾与脑组织二甘醇酸蓄积较无肾损伤动物明显增加。
- 肾损伤动物脑脊液总蛋白较对照组及无肾损伤给药动物明显升高。
- 肾损伤动物前肢握力、运动与直立活动较对照组及无肾损伤给药动物显著下降。
证据类型、等级与局限
- 证据类型:动物实验(非临床研究);原文未给出证据等级或推荐强度。
- 局限:样本量小(43只给药,11只发生AKI)、单一种属、动物模型结果不能直接外推至人体;原文未提及盲法或对照分配细节。
对床旁实践的改变
- 提示二甘醇中毒评估中应监测肾功能,并对发生急性肾损伤者关注延迟神经症状(如握力下降、活动减少);该结论来自动物模型,尚不能作为人体诊疗推荐。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Diethylene glycol (DEG) is an organic compound found in household products but also as an adulterant in medicines by acting as a counterfeit solvent. DEG poisonings have been characterized predominately by acute kidney injury (AKI), but also by delayed neurological sequelae such as decreased reflexes or face and limb weakness.
OBJECTIVES: Characterizing the neurological symptoms of DEG poisoning in a subacute animal model would create a clearer picture of overall toxicity and possibly make mechanistic connections between kidney injury and neuropathy.
METHODS: Male Wistar-Han rats were orally administered doses of 4 - 6 g/kg DEG every 12 or 24 h and monitored for 7 days. Urine was collected every 12 h and endpoint blood and cerebrospinal fluid (CSF) were collected for a renal plasma panel and total protein estimation, respectively. Motor function tests were conducted before and after treatment. Kidney and brain tissue was harvested for metabolic analysis.
RESULTS: Of the 43 animals treated with DEG, 11 developed AKI as confirmed by increased BUN and creatinine levels. Renal and brain DGA accumulation was markedly increased in animals that developed AKI compared to animals without AKI. The total protein content in CSF in animals with kidney injury was markedly elevated compared to control and to treated animals without AKI. Significant decreases in forelimb grip strength and decreases in locomotor and rearing activity were observed in animals with AKI compared to control and to animals without AKI.
DISCUSSION: Repeated dosing with DEG in an animal model produced nephrotoxic effects like those in studies with acute DEG administration. The decrease in motor function and increase in CSF protein were only present in animals that developed AKI.
CONCLUSIONS: These studies show development of neurotoxicity in this DEG animal model and suggest that neurological symptoms are observed only when DGA accumulation and kidney injury also occur.
参考来源
- Jamison CN, Dayton RD, Latimer B, et al. Neurotoxic effects of nephrotoxic compound diethylene glycol. Clin Toxicol (Phila). 2021. PMID: 33475432. doi:10.1080/15563650.2021.1874403
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。